News

  • December 6, 2017

    Nemaura Announces Successful SugarBEAT® Interim Precision Study Results

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®,...

    November 2, 2017

    Nemaura Medical Inc. Reports Second Quarter 2017 Financial Results

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible glucose monitoring system for...

    September 26, 2017

    WallStreet Research™ Announces Availability of Corporate Profile Coverage on Nemaura Medical, Inc.

    WallStreet Research™ (WSR), a top-ranked independent research firm with a history spanning over three decades, today announced that it...

    September 21, 2017

    Nemaura Announces Successful Interim Results for SugarBEAT® European Clinical Trials

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    August 29, 2017

    Nemaura Develops Medical Grade SugarBEAT® Android App for Diabetes Management

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    August 15, 2017

    Nemaura Signs Heads of Terms for sugarBEAT® with Device Technologies for Australia and New Zealand

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    August 9, 2017

    Nemaura Medical Inc. Reports First Quarter 2017 Financial Results

    Nemaura Medical Inc. (OTC: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    August 3, 2017

    Nemaura Appoints Thomas Moore to Board of Directors as Independent Director

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    August 1, 2017

    Nemaura Develops Rechargeable Transmitter for sugarBEAT®

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...

    July 26, 2017

    Nemaura Appoints Dr. Salim Natha to Board of Directors as Independent Director, Chair of Compensation Committee

    Nemaura Medical Inc. (OTCQB: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless...